Position in LGND
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,109
+$1,514 QoQ
Shares Held
13
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#382
of 411 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westfuller Advisors, LLC holds $67,869 across 7 Biotechnology names. LGND ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
692 | $26,960 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $14,964 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22 | $10,928 | |
| 4 | GLUE |
Monte Rosa Therapeutics, Inc.
|
301 | $7,284 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
13 | $4,109 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9 | $2,709 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
38 | $915 |
All Filings in LGND
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,109 | 13 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,595 | 13 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,025 | 16 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,834 | 16 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||